A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Clinical trial NCT02488044 · COMPLETED

Trial details

NCT number: NCT02488044
Sponsor: Aeglea Biotherapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Arginase I Deficiency Hyperargininemia

Start date: 2016-06-01
Primary completion: 2019-02-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.